The tirzepatide starting dose for weight loss is 2.5 mg, injected once weekly, for the first four weeks — whether you’re prescribed Zepbound or Mounjaro. That’s the FDA-confirmed protocol as of the current 2026 prescribing information, and it hasn’t changed since tirzepatide’s original approval.
That starting number surprises some patients, since it’s well below the doses that produced the big weight-loss numbers in clinical trials. Here’s why it’s set that low, and what happens after those first four weeks.
Key takeaways
- The starting dose is 2.5 mg once weekly, for the first 4 weeks, on both Zepbound and Mounjaro — confirmed unchanged in the current 2026 FDA label.
- 2.5 mg is an introductory dose only. It’s not approved as a maintenance dose, and it’s not the dose that drives significant weight loss in trials.
- The dose increases by 2.5 mg every 4 weeks after that, moving toward a maintenance dose of 5 mg, 10 mg, or 15 mg based on response and tolerability.
- The low starting dose exists to reduce gastrointestinal side effects — nausea, vomiting, and diarrhea are most common early in treatment and during dose increases.
- You inject the same 2.5 mg dose every week for the full 4 weeks — there’s no dose increase within that initial period, even if side effects are minimal.
- If you’re switching from another GLP-1 drug, your starting dose may differ from the standard schedule — this should be decided with your provider, not assumed.
Why 2.5 mg, and not a higher starting dose?
Tirzepatide activates two receptors — GLP-1 and GIP — and the body needs time to adjust to that activation. Starting at a low dose and increasing gradually is a deliberate strategy to reduce the gastrointestinal side effects that are most likely early in treatment: nausea, vomiting, diarrhea, and constipation.
This isn’t unique to tirzepatide — every approved GLP-1 and dual-agonist weight-loss drug uses a similar slow-titration approach. Jumping straight to a higher dose would likely produce more severe side effects without meaningfully speeding up results, since the first weeks on any dose are more about tolerability than measurable weight loss.
The starting titration schedule
| Weeks on treatment | Dose | Purpose |
|---|---|---|
| Weeks 1–4 | 2.5 mg | Introductory dose — tolerability, not treatment effect |
| Weeks 5–8 | 5 mg | First increase; still below most maintenance doses |
| Weeks 9–12 | 7.5 mg | Second increase |
| Weeks 13–16 | 10 mg | Often a maintenance-range dose |
| Weeks 17–20 | 12.5 mg | Additional increase if needed |
| Week 21+ | 15 mg | Maximum dose, if tolerated and needed |
Each step requires at least 4 weeks on the current dose before increasing — this isn’t optional or something to shorten on your own. Your provider may also pause an increase, or step back down a level, if side effects are significant at any point.
What to expect during the first 4 weeks
Most patients notice mild GI symptoms in the first days on 2.5 mg — some nausea, a change in appetite, occasional stomach discomfort. These are usually described as mild to moderate and tend to ease as the body adjusts, though individual experiences vary.
Significant weight loss typically isn’t the goal of the 2.5 mg phase. It’s a tolerability step. Most of the measurable weight-loss effect documented in trials comes from the maintenance doses (5–15 mg), not the starting dose — so it’s normal not to see dramatic changes in the first month.
Injection technique matters from the start: rotate injection sites (abdomen, thigh, or upper arm), inject subcutaneously, and take it on the same day each week regardless of meals.
If you’re switching from another GLP-1 drug
Patients moving from semaglutide (Ozempic, Wegovy) to tirzepatide don’t automatically start at 2.5 mg in every case — this depends on your current dose, how long you’ve been on it, and your provider’s clinical judgment. Some providers start at the standard 2.5 mg regardless of prior GLP-1 use; others adjust the starting point. This is a decision to make directly with your prescriber, not something to determine from a dosing chart alone.
Missed a dose during the starting phase?
If you miss your weekly 2.5 mg dose and it’s been less than 4 days, take it as soon as you remember, then resume your normal weekly schedule. If more than 4 days have passed, skip the missed dose and take your next one on the regular schedule. Don’t double up to make up for a missed dose — this applies during the starting phase just as much as at maintenance doses.
What comes after the starting dose
Once you’re past the initial 2.5 mg phase, your provider will guide you through the escalation steps toward a maintenance dose — typically 5 mg, 10 mg, or 15 mg, depending on your response and tolerability. Our guide on tirzepatide’s maintenance dose covers what to expect once you get there, including how long most patients stay on their maintenance dose and the signs it may need adjusting.
If GI side effects become significant at any point during titration, our guide on recognizing when a GLP-1 dose is too high covers the warning signs worth flagging to your provider.
Conclusion
The tirzepatide starting dose for weight loss is 2.5 mg once weekly for the first four weeks, on both Zepbound and Mounjaro — a deliberately low, unchanged-since-approval dose meant to build tolerability before the dose increases toward a maintenance level. It’s not the dose that drives significant weight loss, so it’s normal to see modest results in the first month. What matters during this phase is sticking to the weekly schedule and giving your body the full four weeks before any increase.
If you’re ready to start tirzepatide or want a provider to walk through your specific titration plan, book a free consultation with Heally.
FAQ
What is the starting dose of tirzepatide for weight loss?
2.5 mg, injected once weekly, for the first four weeks. This applies to both Zepbound and Mounjaro and hasn’t changed in the current 2026 FDA prescribing information.
Can I start at a higher dose than 2.5 mg?
No, not under standard FDA-approved dosing. The 2.5 mg starting dose is required for treatment initiation regardless of your target maintenance dose, to reduce the risk of severe gastrointestinal side effects.
How long do you stay on the 2.5 mg starting dose?
Four weeks minimum. Your provider may extend this if you’re experiencing significant side effects, but it can’t be shortened.
Will I lose weight on the 2.5 mg starting dose?
Some patients notice early changes, but the 2.5 mg dose isn’t approved as a maintenance dose and isn’t where most of the measurable weight loss documented in clinical trials occurs. Meaningful results typically build as you reach maintenance-range doses.
What happens after the first 4 weeks on 2.5 mg?
Your dose increases to 5 mg for the next 4 weeks, then continues increasing in 2.5 mg steps roughly every 4 weeks until you reach a maintenance dose your provider determines is appropriate.
Do I start at 2.5 mg if I’m switching from semaglutide?
Not automatically in every case. This depends on your current dose and how long you’ve been on it. Talk to your provider directly rather than assuming the standard schedule applies.
What if I miss my dose during the starting phase?
If it’s been less than 4 days since your missed dose, take it as soon as you remember. If more than 4 days have passed, skip it and resume your regular weekly schedule at the next dose. Never double up.
Is the starting dose the same for Zepbound and Mounjaro?
Yes. Both are tirzepatide at the same doses, and both use the identical 2.5 mg starting dose and titration schedule under current FDA labeling.
Related reading on Heally:
- What is the maintenance dose of tirzepatide?
- What is tirzepatide microdosing?
- How to get tirzepatide with insurance
- Mounjaro vs Zepbound: what’s actually different
Sources
- FDA — Zepbound prescribing information (2026)
- FDA — Mounjaro prescribing information (2026)
- PubMed — SURMOUNT-1 trial results
- Eli Lilly — Zepbound usage guide
- FDA — MedWatch adverse event reporting
Medical disclaimer: This article is for informational purposes and reflects current FDA prescribing information as of September 2026. It does not replace medical advice. Always follow your provider’s specific dosing instructions, and consult a licensed healthcare provider before starting, stopping, or changing any prescription medication.
